There are 2,317 papers on dyslipidemia in aging research: 130 trials and 1,386 observational studies in people, 126 in animals, 1 in cells, 626 reviews. The newest story, Nov 16, 2026: “Diagnosed blood fat disorder linked to environment in China”.
Ultra-processed foods were not clearly linked with dyslipidemia in humans (adjusted model).
“food consumption, according to the NOVA classification, was not associated with changes in the lipid profile of CUME participants over the four-year follow-up period.”
Lifestyle modification program decreases dyslipidemia in humans (menopause transition).
“Evidence-based lifestyle interventions, such as Mediterranean and Dietary Approaches to Stop Hypertension (DASH) dietary patterns along with regular aerobic or resistance training, can help mitigate these adverse lipid changes.”
Dietary pattern decreases dyslipidemia in humans (postmenopausal women).
“Nutritional interventions aimed at modulating the gut microbiota—including Mediterranean, plant-based, and DASH dietary patterns, increased dietary fiber intake, and supplementation with prebiotics, probiotics, polyphenols, phytoestrogens, and omega-3 fatty acids—have shown potential to improve lipid profiles”
Dyslipidemia is linked with worse cognitive function in humans.
“CU individuals with dyslipidemia showed faster decline in z-scores of all domains, i.e., memory, language, attention/executive function, visuospatial and global cognition relative to CU individuals without dyslipidemia.”
Dyslipidemia is linked with higher white matter lesions in humans (stratified by age) (β = 154.0, 95% CI 93.0-215.0).
“For both diabetes and dyslipidemia, the WML volume increased in those aged <50 years (β [95%CI] = 376.5 [209.3-543.8] and β [95%CI] = 154.0 [93.0-215.0], respectively).”
Dyslipidemia is linked with higher stroke-related mortality in patients with dyslipidemia (from 0.5 in 1999 to 2.97 in 2023 (AAPC: 7.47; 95% CI: 6.54 to 8.40, p < 0.01)).
“The AAMR observed a significantly steep incline from 0.5 in 1999 to 2.97 in 2023 (AAPC: 7.47; 95% CI: 6.54 to 8.40, p < 0.01).”
Menopause is linked with higher dyslipidemia in humans.
“Postmenopausal women exhibited higher total cholesterol, LDL, beta lipoprotein, and triglyceride levels, while HDL levels were significantly lower compared to the premenopausal group.”
Inflammation is linked with dyslipidemia in humans (OH-PAH associations with HyperTC/HyperTG in the U.S. population) (mediation proportions: 1.26 %-27.60 %).
“Mediation analysis showed LMR, monocytes, and lymphocytes mediated OH-PAH associations with HyperTC/HyperTG in the U.S. population (mediation proportions: 1.26 %-27.60 %).”
HumansOH-PAH associations with HyperTC/HyperTG in the U.S. populationfemalesn = 1,567
Inflammation is linked with dyslipidemia in humans (multi-omics profiling with causal inference and pathway analysis).
“Multi-omics indicated that the associations were mediated by endogenous biomolecules and pathways, primarily pertinent to CVD, inflammation, and metabolism.”
Humansmulti-omics profiling with causal inference and pathway analysisn = 76
Asia-pacific Journal of Convergent Research Interchange·
Hypertension is associated with dyslipidemia in humans (Overweight or obese patients with prediabetes; hypertensive versus non-hypertensive) (3.6-fold higher risk).
“Hypertensive patients had a 3.6-fold higher risk of dyslipidemia”
HumansOverweight or obese patients with prediabetes; hypertensive versus non-hypertensiven = 104
Asia-pacific Journal of Convergent Research Interchange·
Diabetes mellitus is linked with a higher risk of dyslipidemia in humans (OR=1.568, 95%CI: 1.230-1.998).
“Additionally, individuals with diabetes or hypertension had a 56.8% (OR=1.568, 95%CI: 1.230-1.998) and 47.7% (OR=1.477, 95%CI: 1.299-1.679) higher risk for dyslipidaemia, respectively”
Dyslipidemia is associated with diabetes mellitus in humans (prediabetes at diagnosis).
“Dyslipidaemia, with higher triglyceride levels and lower high-density lipoprotein levels at diagnosis, was more prevalent among the participants who progressed to DM.”
Humansprediabetes at diagnosis2-year follow-upn = 705
Obesity is associated with dyslipidemia in humans (AOR 4.24 (95% CI: 2.34-7.66)).
“obesity (AOR = 4.24, 95% CI: 2.34-7.66), and presence of hypertension (AOR = 1.81, 95% CI: 1.14-2.90) were independently associated with increased odds of dyslipidemia.”
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·
Smoking is linked with a higher risk of dyslipidemia in current heavy smokers and former heavy smokers vs never-smokers (P < 0.001).
“The risk of diabetes, dyslipidemia, and hypertension in current heavy smokers and former heavy smokers were higher than that in never-smokers (all P < 0.001).”
Humansin current heavy smokers and former heavy smokers vs never-smokersn = 78,674
Smoking is associated with dyslipidemia in humans (rheumatoid arthritis).
“Age, body mass index (BMI), female gender, smoking history, glucocorticoid use, and higher DAS28 were identified as independent risk factors for dyslipidemia.”
Dyslipidemia raises the risk of cardiovascular disease in humans.
“dyslipidemia—a multifaceted metabolic state characterized by pathologically elevated lipid concentrations—functions as a primary driver in the pathogenesis of atherosclerosis and subsequent cardiovascular disease.”
Sarcopenic obesity is associated with dyslipidemia in humans (males, sarcopenic obesity vs normal group) (OR 4.15 vs normal group).
“In males, the odds ratios (ORs) of osteoporosis and dyslipidemia in the SO group were 4.21-fold and 4.15-fold higher than those in the normal group, respectively.”
Humansmales, sarcopenic obesity vs normal groupmales
Dyslipidemia is associated with sarcopenia in humans (p = 0.004).
“Correlation analysis revealed a positive association between sarcopenia and BMI, insulin resistance, high triglyceride levels, and the presence of dyslipidaemia”
Dyslipidemia predicts treatment discontinuation in the TPTD group (OR: 0.53, 95% CI: 0.29–0.99, p = 0.05).
“In the TPTD group, dyslipidemia and calcium levels were significantly associated with adherence-related discontinuation (odds ratio [OR]: 0.53, 95% CI: 0.29–0.99, p = 0.05; OR: 0.54, 95% CI: 0.30–0.96, p = 0.03, respectively).”
Across five survey waves from 2011–2020, environmental links to diagnosed blood fat disorders were stronger among earlier-born middle-aged and older adults in China.Across five survey waves from 2011–2020, environmental links to diagnosed blood fat disorders were stronger among earlier-born middle-aged and older adults in China.